Filtered library · Conviction
MEDIUM conviction · 246 dossiers
Every dossier the model currently rates MEDIUM conviction — 246 names, with thesis, invalidation trigger, archetype and catalyst.
All dossiers HUM Humana Inc. fresh MEDIUM Margin-over-volume Medicare Advantage reset reclaimed its trend: the 2026-08-24 close of $386.61 is 2.0% above the prior session and back clear of the last 50-day value observed ($378.33, 2026-08-12), with RSI(14) at 64.6 from 52.5.… IRDM Iridium Communications Inc fresh MEDIUM Deal-arb: $27.00 cash plus a collared RKLB stock leg marks a $54.00 package against the 2026-08-24 close of $47.30, a 12.41% discount. The S-4/A filed 2026-08-24 finally dated the special meeting (2026-09-24), but RKLB at $68.28 sits just… MRCY Mercury Systems Inc fresh MEDIUM Defense-electronics turnaround still re-rating on record bookings and a promised FCF turn, but the stock has given back ~20% from its $128.45 ATH and now chops near the analyst median (~$103) into a binary ~Aug 10-18 Q4/full-year print.… MU Micron Technology, Inc. fresh MEDIUM Contract-annuity leg intact — 16 take-or-pay deals, ~$100B minimum contracted revenue to late 2030 — but on 2026-08-24 the tape found a counter-narrative: reports the White House may let Apple source DRAM from CXMT ahead of Xi's ~09-24… OKTA Okta, Inc. fresh MEDIUM Identity-security re-rating in its second, sell-side-led leg; the upgrade wave is still building nearly two months post-print — Wells Fargo lifted its target to $150 from $100 on 2026-07-20, collapsing the low-end dispersion. Cyber theme… RXO RXO, Inc. fresh MEDIUM Freight-cycle recovery intact; sell-side has fully caught up into a $20–35 battleground — bears $20 (Goldman 07-16, Susquehanna 07-14), bulls $30–35 (BMO $35 initiation 07-14, Stifel/Truist/Citi $30). Narrative matured from mispriced to… CRWV CoreWeave, Inc. fresh MEDIUM Post-print repricing is holding but fading: the 2026-08-12 gap to $107.73 is unfilled after closes of $106.29 and $105.26, RSI 71.1. Q2 printed $128M adjusted operating income against a $30–90M guide, and the $2.6B facility closed… HOOD Robinhood Markets, Inc. fresh MEDIUM The 2026-08-21 breakout above the $97.28/$98.87 band held its weekly close at $108.13, then gave 4.2% back to $103.62 on 2026-08-24 — still above the band, follow-through above $109.25 rejected. The dated binary is the 2:15 p.m. ET cloture… UUUU Energy Fuels Inc. fresh MEDIUM Mine-to-magnet milestone cadence still driving the tape, but paying less each time: the 2026-08-19 terbium qualification bought one session (08-21 close $15.14, +8.92%) then faded to $14.88 on 08-24, back under the 08-14 shelf of $15.10.… AMD Advanced Micro Devices, Inc. fresh MEDIUM AI-compute narrative re-accelerated on the 2026-07-23 analyst event — named multi-gigawatt Anthropic/OpenAI commitments, Helios rack-scale ramp, TAM lifted to $2T by 2030 — drawing a fresh upgrade cluster (Roth $650, Cantor $700, Futurum… ATI ATI Inc. fresh MEDIUM Titanium/superalloy aero-defense supplier digesting a June breakout above the reclaimed $183.30 ATH shelf: ~9% off the $204.09 high, RSI cooled to ~66, consensus PT $200.33 back above spot. Q2 lands 2026-08-06; peer CRS prints 2026-07-30… NBIS Nebius Group N.V. fresh MEDIUM GPU-neocloud narrative re-accelerated after NVIDIA disclosed a 9.3% stake (7/20) and PT raises followed (Northland $410, Baird initiates Outperform $250); Alphabet's 7/22 "demand outpaces capacity" answers the Meta-Compute bear case. The… VRT Vertiv Holdings Co fresh MEDIUM Liquid-cooling/datacenter-power bottleneck story intact but the revision cycle has stalled — RBC cut its target and the two newest sponsors (Baird $370, KeyBanc $360 on 07-23) initiated at the bottom of the range as the theme cooled to… WTI W&T Offshore, Inc. fresh MEDIUM War-premium crude expression left for dead in early July has violently re-fired: the June-17 US–Iran MOU collapsed, nine nights of US airstrikes and a July-7 Hormuz tanker attack drove WTI crude +~20% to $83 (Jul 20). Unlike May, the… WULF TeraWulf Inc. fresh MEDIUM Bitcoin-miner-to-HPC re-rate confirmed by Anthropic's 20-year ~$19B lease (2026-07-06); theme accelerating and cluster-confirmed (Hut 8's $9.8B deal, 2026-07-20). A ~$3.5B financing overhang, the NY hyperscale moratorium aimed at Lake… ABT Abbott Laboratories MEDIUM De-rating unwind is now largely priced: $82.56 close on 2026-05-11 to $111.25 on 2026-08-14, RSI 72.2, with the 2026-08-11 Google Health/Lingo partnership and Wolfe's 2026-08-13 upgrade to $130 as the newest fuel. Nothing tests the… ACIW ACI Worldwide, Inc. MEDIUM Special-situation breakup narrative accelerating: Reuters (2026-07-17) reports ACI exploring a ~$1.5B sale of its Biller unit, which would surface sum-of-the-parts value and re-rate the faster-growing Payments Software segment. Q1 beat +… ACLS Axcelis Technologies, Inc. MEDIUM Beat-and-raise on 2026-08-06 (Q2 rev $215.175M vs $204.985M est; Q3 guided $230.0M vs $214.846M) repaired the fundamental case, but price only recovered to the top of the July band at $140.15 (08-14), 26.9% under the $191.6 high. China… ADBE Adobe Inc. MEDIUM Deep-value AI-disruption leg in legacy software, now with an external validator: the 2026-08-13 Silver Lake–Workday take-private report put a sponsor price on marked-down per-seat SaaS. ADBE closed 2026-08-14 at $264.02, 28.2% off the… ADPT Adaptive Biotechnologies Corporation MEDIUM clonoSEQ MRD pure-play inflecting to self-funding growth (MRD rev +53% YoY, profitability turning); June 15 Immune Medicine separation adds a value-unlock leg. But the tape just broke to fresh 52-wk highs (~$22.92) above the $20–22… AGIO Agios Pharmaceuticals, Inc. MEDIUM Mitapivat SCD label-expansion binary into a 2026-11-01 PDUFA, now with a real commercial leg under it: Q2 mitapivat revenue $44.7M vs $26.03M consensus (2026-07-30), yet the tape gave the beat back — $33.56 close on 2026-08-14, RSI 35.8,… AKAM Akamai Technologies, Inc. MEDIUM Legacy-CDN-to-AI-inference pivot got its first external validation since the failed July bounce: Q2 CIS +39% to $99M with >$2.8B YTD contract bookings (2026-08-06), then J.P. Morgan off Underweight to Neutral, PT $158 (2026-08-13). Price… AKTS Aktis Oncology, Inc. MEDIUM The "coverage is spent" read broke: Wedbush ($35) and BMO ($37) initiated Outperform on 2026-08-19, taking the cohort to five, and the 2026-08-13 Q2 reaffirmed Q1 2027 AKY-1189 data with $517.3M cash. Price did not follow — $24.07 on… ALAB Astera Labs, Inc. MEDIUM Q2 (2026-08-04) answered the July margin question: GM 73.7% vs ~73% guide, and Q3 guided $540–560M vs $416.5M consensus (~40% QoQ) with Scorpio X switches in volume production a quarter early. Price has not confirmed — the 2026-08-14 close… ALGT Allegiant Travel Company MEDIUM Allegiant closed the $1.5B Sun Country acquisition (2026-05-13) to become the largest US leisure airline just as fuel flipped to a tailwind and the whole sell-side re-rated it to $142–$160; the move has more than doubled off the low, and… ALKS Alkermes plc MEDIUM Legacy CNS base converting into an OX2R sleep franchise; the mechanism was validated by the FDA's 2026-08-05 approval of Takeda's ORZEYFUL, yet ALKS closed 2026-08-21 at $48.33, 12.5% under its $55.22 high. Catalyst-light until the… AMBA Ambarella, Inc. MEDIUM Physical-AI pure-play narrative still accelerating (Rosenblatt top H2-2026 pick, PT $120; Zacks upgrade to #2 Buy 2026-07-21), but the post-Rosenblatt breakout to ~$80 round-tripped to ~$67.61 by 2026-07-24, forfeiting the $72 shelf on a… AMC Amc Entertainment Holdings, Inc. MEDIUM Box-office recovery flipped from meme-squeeze dormancy to a fundamental earnings inflection: Q2 (2026-07-20) adj EPS $0.14 vs $(0.06) est, revenue $1.597B beat, plus a Wedbush $4 / Benchmark $3 upgrade cluster (2026-07-21). Narrative… AMPL Amplitude, Inc. MEDIUM Post-print re-rate extending: 2026-08-21 close $13.29 is 0.1% under the 52-week high after a 98.4% three-month move, with Morgan Stanley to $16 (2026-08-13) and BofA to $14 (2026-08-20) lifting the ceiling above the $13 post-earnings… AMRX Amneal Pharmaceuticals, Inc. MEDIUM Legacy-generics-to-specialty re-rate with both 2026 tests cleared — 2026-07-30 Q2 beat plus a second FY2026 raise, Kashiv closed 2026-08-10 on $350M of term loan and 28.9M Class A shares — but the tape has faded to a 2026-08-21 close of… AMZN Amazon.com, Inc. MEDIUM AWS reacceleration is now measured rather than hoped: +37% YoY to $42.2B on 2026-07-30, fastest in 18 quarters, and the stock took $3T at a record $284.02 close on 2026-08-03. Half that move was back by the 2026-08-14 close of $262.65; the… ANDG Andersen Group Inc. MEDIUM Post-IPO roll-up re-rate that survived its binary: Q2 revenue $217.7M beat $199.3M on 2026-08-12 and FY2026 was affirmed at $980M–$1.0B, with four target raises to $49–57 on 2026-08-13. The print is behind it and no dated catalyst sits… APH Amphenol Corporation MEDIUM AI-interconnect content leg intact — orders $10.7B, book-to-bill 1.23:1, Q3 guided above consensus — but the flow turned: $169.18 on 2026-08-07 to $157.01 on 2026-08-21, including a 6.6% one-day drop on 2026-08-18 with no company news.… ARES Ares Management Corporation MEDIUM Private-credit compounder still saturated rather than broken: Q2 (2026-07-31) showed AUM $671B, $36B inflows and FRE $491.1M, yet the 2026-08-21 close of $141.25 sits 20.7% under the $178.13 trailing high. Since 2026-08-12 nothing has… ARXS Arxis, Inc. MEDIUM Sponsor carve-out compounding into a Defense & Space upcycle, but the 2026-07-29 guide raise to $1.96–1.98B is now in the price. Omnetics closed 2026-08-17 at $770M EV, paid principally in 13.35M Class A shares. Momentum has reset —… ATEYY Advantest Corporation MEDIUM The 2026-07-29 Q1 print broke the H2 digestion flag: FY2026 guide raised to ¥1,714.0B sales / ¥846.0B operating income, CY2026 tester TAM lifted to $13.0–14.5B from $10.9–12.2B, and the ADR made a new 52-week high at $235.00 on 2026-08-14.… ATRC AtriCure, Inc. MEDIUM Profitability-inflection leg now confirmed by price: the 2026-08-14 close of $44.30 is a fresh 52-week high on RSI(14) 76.0. The 2026-07-23 raise (FY2026 adjusted EPS $0.00–$0.04 to $0.24–$0.32 against $0.06 consensus) is three weeks old,… AU AngloGold Ashanti plc fresh MEDIUM Gold-miner margin leverage at a fresh high: spot $4,607/oz on 2026-08-21 (+11.54% MoM) turned Q2 free cash flow to $727M and the balance sheet to $991M net cash, but the same 2026-07-31 print missed on EPS ($1.98 vs $2.18) and revenue.… AUR Aurora Innovation, Inc. MEDIUM Q2 (2026-07-29) cleared the binary without breaking the plan: >200 driverless trucks and ~$80M exit run-rate reaffirmed, FY26 revenue guided $14–16M, ~$1.2B cash after a $215M net ATM raise. Price reclaimed the broken ~$6.00 June shelf to… AUTL Autolus Therapeutics plc fresh MEDIUM Commercial-execution re-rating still working on no new information: after the 2026-08-03 guidance raise to $140–150M and the 2026-08-11 Q2 beat ($45.7M vs $34.0M consensus), the shares printed a new 52-week high at $2.54 and closed $2.41… AVAH Aveanna Healthcare Holdings Inc. MEDIUM Fourth FY2026 guide raise (2026-08-13: adj EPS $0.22 vs $0.17, EBITDA floor to >$365M) carried price to a $13.16 52-week high; eight days later J.H. The overhang now has a dated clearing price, and nothing is scheduled until the ~November… AYA Aya Gold & Silver Inc. MEDIUM Silver back near $69.6/oz on 2026-08-21 from $64.96 a week earlier puts Q3 realized pricing above Q2's $64.22/oz AgEq, restoring the price leg the prior read had written off — but the equity lagged, closing CA$36.66 against a CA$40.16… BABA Alibaba Group Holding Limited MEDIUM Cloud/AI re-rating leg picked up an Apple attachment — Reuters reported 2026-08-14 that Apple trained a China-specific LLM with Alibaba's support — Price faded the other way, $128.41 on 08-07 to $123.81 on 08-14, 34.0% under the 52-week… BBAR Banco BBVA Argentina S.A. MEDIUM Argentina country trade re-accelerated: June CPI printed 1.9% MoM on 2026-07-14 (first sub-2% of the cycle) and country risk broke to 402bp, tightest since April 2018, carrying BBAR to a fresh 52-week high of $22.47. Price now sits above… BBNX Beta Bionics, Inc. MEDIUM Q2 (2026-07-29) resolved the binary the right way: new patient starts rose sequentially (banded +10–20%) after Q1's decline, net sales $32.0M +38% YoY, FY26 gross-margin floor raised to 58.5–59.5%. The frame flipped from broken-growth to… BE Bloom Energy Corporation MEDIUM Q2 (2026-07-28) beat and raised — revenue $1.065B +165.5% YoY, FY26 guide lifted to $3.9–$4.2B — yet the 2026-08-14 close of $229.94 sits 33.5% below the 52wk high after July's 32% Hunterbrook-driven drawdown. Accelerating P&L into a… BETA Beta Technologies, Inc. MEDIUM The 2026-08-12 print resolved the binary split: revenue $14.658M beat the $9.752M consensus and FY26 revenue was guided up to $42–50M from $39–43M, but EPS missed at $(0.64) and backlog dollars sat flat at $3.9B for a second quarter.… BH Biglari Holdings Inc. MEDIUM Q2 10-Q (filed 2026-08-07) answered the dilution question early: six-month issuance proceeds of $14,920k do not exceed the $15,073k of ATM sales already disclosed through 2026-05-08, so nothing material was sold into the June run to… BHE Benchmark Electronics MEDIUM Beat-and-raise on 2026-07-29 (rev $756M +18% YoY, AC&C +71% YoY, FY26 lifted to ~$3B/+13%) was fully sold: price round-tripped from the $98.67 52-week high to $81.75 on 2026-08-14. The AI-cooling and lidar picks-and-shovels leg is… BILL BILL Holdings, Inc. MEDIUM Self-help re-rate cleared its binary on 2026-08-19: Q4 core revenue +16%, 23% non-GAAP operating margin, FY2027 EPS guided $3.56–$3.79 vs $3.35 consensus — and the stock still fell 2.97% the next day, closing $47.82 on 2026-08-21 under all… BLZE Backblaze, Inc. MEDIUM Neocloud storage pick-and-shovel: the five-year ~$335M CoreWeave B2 Neo deal (2026-06-23) re-rated BLZE from the high-$7s to a 52-week high near $18, and sell-side is still chasing (Citizens to $16, 2026-07-23). Narrative accelerating but… BMY Bristol-Myers Squibb Co. MEDIUM Legacy-pharma re-rate off the 2026-07-30 guidance reset ($49.0–50.0B sales, $6.75–7.00 adj EPS) is intact, but both attention legs are spent: the AstraZeneca merger was denied 2026-08-05 and the FDA approved ZENBEXUS on 2026-08-13, four… BULL Webull Corporation MEDIUM June dormant-to-leader flip is confirming: the ~$7.52 breakout resolved up on the 2026-07-21 surge, Rosenblatt lifted its target to $13 (2026-07-16), and June ops printed 28.2M users / $800M net deposits. Theme accelerating; read is a… BVS Bioventus Inc. MEDIUM Two weeks past the 2026-08-05 unsolicited-proposal disclosure the M&A leg is intact but undated: no committee update in 12 sessions, price consolidating at the 2026-08-21 close of $14.38 against the $15.26 high while RSI(14) unwound 70.5… BWLP BW LPG Limited MEDIUM Hormuz VLGC rate shock now hangs on one date: the 2026-08-28 H1 report tests ~85% of Q2 days pre-fixed near $81,000/day (guided 2026-06-02) against the -$31M Product Services quarter flagged 2026-07-16, and sets the Q2 dividend against… CACI CACI INTERNATIONAL CLA MEDIUM Services-to-defense-tech re-rate off the 2026-08-05 FY2027 guide reset (adj EPS $32.96–33.86 vs $30.78 consensus, FCF ≥$900M) is now digesting: the 2026-08-17 NITE-STAR award made no new high, and the 2026-08-21 close of $647.39 sits back… CADL Candel Therapeutics, Inc. MEDIUM Pre-BLA re-rating re-armed: July's round-trip reversed, price reclaimed the June $11.36 high and closed 2026-08-14 at $11.72, 0.7% under the 52-week high, after the 8/13 Q2 print reaffirmed a Q4 2026 prostate BLA and $201.6M cash into Q1… CAL Caleres Inc MEDIUM July chop resolved up: $11.78 (2026-07-24) to $13.37 (2026-08-14) reclaims the low-$13s shelf lost after the June print, while the ~$57.8M IEEPA refund moved from legal abstraction to a live CBP payment queue ($128.68B accepted for… CCC CCC Intelligent Solutions Holdings Inc. MEDIUM Cheap, high-margin insurtech SaaS put in play: a Morgan Stanley-run sale process plus a fresh Elliott activist stake. Shares popped ~13% to ~$6 on the 2026-07-09 Reuters report yet still sit below a plausible PE take-out. The trade is… CCS Century Communities, Inc. MEDIUM Post-Q2 re-rate is consolidating rather than extending: the 2026-08-21 close of $69.78 is 5.8% under the $74.04 high with RSI 52.4. August HMI ticked up to 35 and Freddie Mac fell a second week to 6.65%, but July single-family starts… CDNA CareDx, Inc. MEDIUM Post-LCD estimate-revision leg is intact but the flow has moderated: no company headline between 2026-08-07 and 2026-08-21, yet a new closing high of $48.61 with RSI(14) down to 53.3 from 70.1. The 2026-08-30 LCD effective date is a… CERT Certara, Inc. MEDIUM Guidance held rather than got cut again: the 2026-08-04 Q2 print reaffirmed FY26 revenue $367-382M and adj EPS $0.31-0.36 despite a revenue miss, and the $6.87 premarket gap round-tripped to an $8.43 close on 08-21. The leg is self-help —… CGEM Cullinan Therapeutics, Inc. MEDIUM CD19 T-cell-engager-in-autoimmune narrative re-rated CGEM ~3x off the $5.68 low on CLN-978 lupus/RA single-dose remissions; now drifting to ~$17.10 in a bull flag under the $19.43 high with the big data catalyst spent and no dated readout… CLDX Celldex Therapeutics, Inc. MEDIUM Single-asset binary: Phase 3 EMBARQ-CSU1/CSU2 topline guided to September/October 2026 at the 2026-08-06 print is the entire equity. The re-rating leg is built — 52-week high $44.87, three Overweight raises 07-29 to 08-07 — and has since… CLF Cleveland-Cliffs Inc. fresh MEDIUM FCF-inflection thesis confirmed: Q2 (2026-07-23) delivered positive free cash flow and a sales beat, the stock gapped ~19%, and GLJ flipped to Buy ($15.6) — first above-spot target. The GOES-into-grid narrative is re-accelerating, but a… CLOV Clover Health Investments, Corp. MEDIUM Q2 (2026-08-05) resolved the binary upward — revenue $743.2M +56%, adj EBITDA $41M, FY guide lifted on every line to $2.92–3.00B revenue and $20–35M GAAP net income — but the 52-week high of $5.41 was sold to a $4.60 close on 2026-08-14… CLW Clearwater Paper Corporation MEDIUM SBS paperboard price inflection: two $60/ton increases plus ~300kt of capacity out YTD took Q3 adjusted EBITDA guidance to $20–30M from negative $8M in Q2. The overbought condition at the 2026-08-07 high of $23.31 has worked off — RSI(14)… CMCO Columbus McKinnon Corporation MEDIUM First full combined quarter post-Kito Crosby beat hard (adj EPS $0.61 vs $0.27 est) and drove a guidance raise on all three lines on 2026-07-30; the leg being bought is deleveraging from 4.9x toward sub-4x by FY28 on $70M of synergies. No… CME CME Group Inc. MEDIUM Event-contract and 24/7 pivot got dates: NHL FutureSports futures 2026-09-28, Silicon Data H100/B200 compute futures 2026-10-05, 24/7 silver 2026-09-11 — all announced 2026-08-11. Price recovered to $274.98 (2026-08-21) but still sits… CMG Chipotle Mexican Grill, Inc. fresh MEDIUM Outbreak drawdown is repairing: the federal count rose from 345 cases/27 states (2026-08-14) to 431/32 (2026-08-19) while the stock went from a $33.50 close on 08-14 to $36.90 on 08-21, reclaiming the $35 shelf. CDC dates illness onsets… CMPS COMPASS Pathways Plc MEDIUM Clinical binary resolved 2026-07-07; what trades now is regulatory execution — rolling NDA completion guided Q4 2026, H1 2027 launch, $433.3M cash into 2028. The empty calendar just filled: FDA holds a public hearing 2026-09-14 on… CODI Compass Diversified MEDIUM Q2 (2026-08-10) reframed the name: adj EPS $(0.09) missed $0.09 est, but Subsidiary Adj EBITDA rose 12.6% to $91.5M and covenant leverage fell 5.3x to 4.8x. TD Cowen went $12.50→$18. Riley upgraded to Buy at $15 on 2026-08-11; three… COHU Cohu, Inc. MEDIUM Best fundamental print of the AI cycle (2026-07-30: rev $149M vs $144.08M cons.; Q3 guided $163–177M vs $146.33M) collided with a sector de-rate — the stock closed $52.88 on 2026-08-07, 28.5% under its $73.91 high and beneath the June… CRAI CRA International, Inc. MEDIUM Beat-and-raise from 2026-08-06 — record $210.8M quarter, FY26 constant-currency guide lifted to $805–820M — has only partly repriced: $176.90 on 2026-08-21, still 20.2% under the $221.74 high, with no company news since the print. The leg… CRDO Credo Technology Group Holding Ltd MEDIUM Interconnect/AEC royalty narrative still accelerating, not fading — new 52-week highs on late-June initiations (Evercore $325, Stifel $350, BofA $340) plus the early-July AI-buildout rally. But it's now mainstream and widely held, entering… CRM Salesforce, Inc. MEDIUM De-rated Dow software incumbent on two dated legs: the $1.6B VA agentic ELA (2026-07-24) and Reuters' 2026-08-13 report of Silver Lake–Workday take-private talks, which put a private-market floor under mega-cap SaaS. Six target revisions… CSTL Castle Biosciences, Inc. MEDIUM Mix-shift repair leg extended without new fundamental content: $29.62 on 2026-08-14 to $34.20 on 2026-08-21, with only an 08-17 Nasdaq Texas dual listing and an 08-20 conference schedule filed in between. TissueCypher +64% YoY still… CTOS Custom Truck One Source, Inc. MEDIUM Utility T&D / grid-capex cycle with CTOS as the laggard specialty-rental picks-and-shovels name; the June breakout to $11.36 has stalled, retracing ~10% to retest the ~$10 shelf into a binary 2026-07-29 Q2 print. Theme now maturing and… CVI CVR ENERGY, INC. MEDIUM Frame flipped since the 2026-08-08 note: a refined-products squeeze repriced CVI from $31.15 (2026-08-07) to $39.51 (2026-08-21), 0.6% off the 52-week high, on a record $102.20 diesel crack (2026-08-17) — not a company event. Consensus… CYRX CryoPort, Inc. MEDIUM Q2 (2026-08-06) split the read: revenue $49.0M beat $48.21M and FY26 guide affirmed at $192–196M with adjusted EBITDA crossing to +$0.4M, but commercial CGT growth halved to +9% YoY from +26%. The narrative leg is now the profitability… DCTH Delcath Systems, Inc. MEDIUM Post-print leg held and extended — 2026-08-21 close $17.14, 1.3% under the 52-week high of $17.36 — while the news line went quiet after the 2026-08-11 conference appearance. Nothing company-confirmed is dated until ESMO (2026-10-23) and… DFIN Donnelley Financial Solutions, Inc. MEDIUM Mix-shift leg intact and untested since the 2026-07-30 Q2 print — software 44.3% of net sales, record 36.7% adjusted EBITDA margin — with no company headline in the three weeks since. Shares closed $48.23 on 2026-08-21, 15.3% under the… DGII Digi International Inc. MEDIUM Hardware-to-ARR re-rating accelerating: the 2026-08-05 Q3 print put ARR at $191M (+52% YoY) with a record 29.1% adj-EBITDA margin, and FY26 revenue guidance jumped to $529–533M from $490–508M. Price closed 2026-08-14 at $85.12, 0.1% off… DINO HF Sinclair Corporation MEDIUM Post-print leg extended rather than renewed: a fresh 52-week high at $97.32 (2026-08-21), +40.1% over three months, built on the 2026-07-28 beat ($5.31 vs $4.54), the Lubricants spin-off plan and the 2026-08-11 $5B Western Gateway FID.… DK Delek US Holdings, Inc. MEDIUM Record distillate cracks ($102.20/bbl diesel, 2026-08-17) converted a sold-off Q2 beat into a breakout: the 2026-08-21 close of $71.47 was up 11.60% in one session and a 52-week closing high, above the $64.00 12-analyst mean target.… DNTH Dianthus Therapeutics, Inc. MEDIUM Complement re-rate has gone quiet: no company disclosure since the 2026-08-04 Q2 print, a fresh 52-week high at $115.96 on a lower RSI than the early-August one, and the next dated binary — MoMeNtum MMN top-line — not until December 2026.… DRTS Alpha Tau Medical Ltd. MEDIUM Head-and-neck re-acceleration: a 2026-06-23 first-ex-US glioblastoma treatment drove a +17.9% breakout to new 52-week highs (~$12.56 on 7/11), reclaiming the $11.99 Tolmar equity shelf. The 2026-07-21 AHNS podium with complete Alpha DaRT +… DYN Dyne Therapeutics, Inc. MEDIUM maturing — nothing company-dated until the ~late-October Q3 print, then the 2027-01-21 PDUFA. ELE Elemental Royalty Corporation MEDIUM Post-EMX royalty roll-up compounding fast: Q2 2026 revenue $23.8M vs $9.1M a year earlier, record 5,248 GEOs, guidance affirmed at 17,000–21,000 GEOs (2026-08-11), Vizsla Royalties silver leg targeted to close Q3 2026. Narrative… ELF e.l.f. Beauty, Inc. MEDIUM Sell-side flipped from cutting to marking up in ten days — five PT raises 2026-07-10→07-17 (JPM $94, Canaccord $97, Citi $92, RJ $87, UBS $80) on the e.l.f. Hair launch and Rhode scaling, while the stock slipped to $72.25. Narrative… ELVN Enliven Therapeutics, Inc. MEDIUM Funded single-asset CML story broadening its shareholder base: Barclays initiated Overweight $78, William Blair Outperform and Mizuho raised to $73 all on 2026-08-18, yet the 2026-08-21 close of $59.82 sits 2.1% under the $61.11 high with… ENTG Entegris, Inc. MEDIUM June's sentiment re-rate rolled over; the 2026-08-04 beat-and-raise re-based the story on numbers — Q2 sales $883.2M vs $835.5M consensus, Q3 guide $905–935M vs $879.8M — and drew three target raises on 08-05 (UBS $215). At $152.08 the… ENVA Enova International, Inc. MEDIUM Credit-normalisation plus origination growth still working, but the repricing has stalled: $242.93 on 2026-08-21 is 8.5% under the $265.45 high with RSI 37.6 after a +54.2% three-month run. Two August filings cut funding cost (ABS priced… EOLS Evolus, Inc. fresh MEDIUM Margin-inflection re-rating still paying: Q2 (2026-08-05) printed $84.1M revenue (+21% YoY) and a third straight positive adjusted EBITDA quarter, and price has since marked a new 52-week high at $8.60 (2026-08-21 close $8.39, RSI 77.3).… ETON Eton Pharmaceuticals, Inc. MEDIUM Q2 on 2026-08-13 resolved the binary upward — product sales $37.6M vs $27.1M consensus, FY26 guide to >$145M from >$120M — and four brokers raised targets inside four sessions. Accelerating, but priced into the top of the published targets. EVER EverQuote, Inc. MEDIUM The 2026-08-03 Q2 print resolved the plateau binary bullish: revenue $195.1M (+25% YoY) broke the three-quarter ~$190M band, adjusted EBITDA hit a record $30.1M, and Q3 was guided $198–208M above the $201.6M consensus. The leg is now… EXLS ExlService Holdings, Inc. MEDIUM Refinancing overhang cleared 2026-08-18 — a new up-to-$1.0B facility ($400M term loan, revolver to $600M, 2031 maturity) replaced the Citibank agreement that had $381.2M sitting in the current column — and EXLS broke its mid-$34s shelf to… FA First Advantage Corporation MEDIUM Aug 6 flipped the frame: Q2 revenue $448.8M/+14.9% vs $415.0M consensus, adj EPS $0.35 vs $0.28, and the first FY guide raise of the cycle ($1.67–1.71B). Needham upgraded to Buy/$28, RBC to $24 — targets moved above spot for the first… FET Forum Energy Technologies, Inc. MEDIUM Oilfield-equipment operating-leverage re-rating, now maturing: the 2026-07-30 Q2 beat ($1.16 adj EPS vs $0.56) and raised FY26 guide were reiterated at EnerCom on 2026-08-18 ($890M revenue, $120M EBITDA). Price made a $86.31 52-week high,… FIGS FIGS, Inc. MEDIUM Growth re-acceleration re-rated the name on the 2026-08-06 Q2 print (revenue +28.8% to $196.6M, FY2026 guide to $757.318M, buyback doubled to $200M), and eleven sessions later the gap is unfilled — the 2026-08-21 close of $14.68 sits above… FORM FormFactor, Inc. MEDIUM Probe-card pick-and-shovel to the HBM4 test ramp; after a parabolic run to a fresh $160.27 ATH (2026-06-30) on Russell 1000 inclusion, the 2026-07-02 chip selloff cut FORM ~24% to ~$121. HBM inflection intact (record DRAM quarter, second… FOSL Fossil Group, Inc. MEDIUM The 2026-08-12 binary resolved bullish: Q2 sales $209.7M beat a $199.3M consensus, gross margin expanded 490bps to 62.4%, and FY2026 guidance was raised on sales (-3%/-5%), adjusted operating margin (4-6%) and free cash flow (positive).… FROG JFrog Ltd. MEDIUM Software-supply-chain-security plus AI-agent "trust layer" narrative keeps re-rating: the analyst cluster now leads price above $100 (UBS Buy $110 Jul 2, Truist Buy $105 Jul 9), confirming the continuation tell flagged in June.… FSLR First Solar, Inc. MEDIUM Section 232 supplied a new leg: the 2026-08-06 proclamation sets a $0.38/W minimum import price on modules from 2026-12-04, above the ~$0.36/W FSLR struck on Q2 US bookings. Baird upgraded 2026-08-11 with a target moved to $318 from $205.… FSLY Fastly, Inc. MEDIUM The Q2 margin inflection finally got paid, five sessions late: shares moved ~21% on 2026-08-10 to $27.69 intraday, the highest since early 2024. Three insiders then disposed at $28.60–$30.00 on 2026-08-18 and the 2026-08-21 close was… FTK Flotek Industries, Inc. MEDIUM Legacy oilfield chemistry re-rating into a power/measurement business: Data Analytics hit 51% of gross profit in Q2 2026, the 2026-08-03 PREPA award adds ~$400M of 10-year expected backlog, and the 2026-08-04 guide went to $340–350M from… FTNT Fortinet, Inc. MEDIUM Q2 (2026-07-29) resolved up — revenue $2.047B vs ~$1.89B, product +52% YoY, FY26 guide raised to $8.020–8.180B — but price has gone nowhere since: $161.95 on 07-31, $160.01 on 08-14, still 4.9% under the $168.29 high. The 44-analyst mean… GCT GigaCloud Technology Inc MEDIUM Post-print leg digesting, not breaking: after the 2026-08-06 Q2 beat ($411.6M, +27.6% YoY; GM 25.6% vs 23.9%) took GCT to a 52-week-high close of $53.25 on 08-07, ten sessions with no company headline cooled it to $49.65 with RSI(14) back… GEN Gen Digital Inc. MEDIUM Post-print leg holding on an empty calendar: Q1 FY27 (2026-08-06) beat and lifted FY27 to $5.375-5.475B, the 2026-08-17 ex-div session probed $27.41 and was reclaimed to $28.93 by 2026-08-21, and the $32.11 consensus has not moved since… GERN Geron Corporation MEDIUM Narrative leg rotated on 2026-08-05/06: RYTELO revenue accelerated to $57.5M (+11% QoQ) and quarterly cash draw shrank to ~$14M from $60M, while management reframed IMpactMF's base case to the H2 2028 final OS analysis — so the… GH Guardant Health, Inc. MEDIUM Q2 (7/30) beat and lifted FY26 to $1.340–1.360B, but the second target wave on 8/3–8/4 (Stephens $195, Piper $193, MS $185) again failed to clear Citi's $215 from 7/8. Fundamentals still stepping up while the sell-side ceiling has been… GHRS GH Research PLC MEDIUM Eli Lilly's up-to-$3.8B AtaiBeckley buy (2026-07-16) put a large-cap price on 5-MeO-DMT for depression; GHRS is now the last independent pure-play, with best-in-class inhaled GH001 Phase 2b data, that the sector is repricing as the next… GRND Grindr Inc. MEDIUM Q2 (2026-08-06) resolved the binary bullishly — revenue $138.1M +33% vs $132.4M consensus, FY guide to ~$540M/~$232M EBITDA, three PT raises 2026-08-07 — yet price faded from the ~$18 area on 2026-08-03 to a $16.01 close on 2026-08-14.… HIMX Himax Technologies, Inc. MEDIUM Q2 beat and an above-consensus Q3 guide (2026-08-06) plus Baird's $43 target (2026-08-07) failed to hold a price — $13.79 close on 2026-08-21, under the $14.61 post-print close, 42.0% below the $23.79 high. WiseEye's first commercial… HMY Harmony Gold Mining Company Limited fresh MEDIUM Gold-miner margin leverage with a new copper leg: the 2026-08-21 trading statement pre-released FY26 EPS up 90–108% in rand on US$3,811/oz received vs US$2,195/oz AISC, and spot gold at $4,607/oz sits well above that realised price. The… HNI HNI Corporation MEDIUM Steelcase synergy capture confirmed on the 2026-07-30 Q2 print — non-GAAP EPS $1.27 vs $1.04 consensus, FY2026 guide lifted to 20–25% growth from mid-teens — and the legacy-furniture value trap re-rated from $39.70 (2026-07-15) to $48.86… HPK HighPeak Energy, Inc. MEDIUM Q2 (released 2026-08-10) answered the cash question: EPS $0.59 vs $(0.07) consensus on $272.4M revenue vs $232.2M, and the stock closed 2026-08-21 at $8.32, a 52-week high, versus $7.20 pre-print. The leg being bought now is the harvest… HPP Hudson Pacific Properties, Inc. MEDIUM The refi binary now has a filed date: the 10-Q (2026-08-10) puts the Hollywood Media Portfolio loan maturity at 2026-09-09 with the longer-term extension still unresolved. Q2 beat ($0.35 Core FFO vs $0.26) and three August target raises… HRI Herc Holdings Inc. MEDIUM Second-order AI/power play: Herc rents the cranes and gensets that build data centers. Peer United Rentals raised FY26 guidance (2026-04-23), confirming an accelerating theme — but the stock sits +71% off its low and drifts into a binary… HTZ Hertz Global Holdings, Inc MEDIUM The 2026-08-06 Q2 beat re-lit a squeeze the index deletion had just flushed: adjusted corporate EBITDA $81M cleared the top of a $50–80M guide, GAAP swung to +$64M, and the stock ran roughly 50% in two sessions amid 73.85%-of-float short… HURN Huron Consulting Group Inc. MEDIUM AI-disruption discount still unwinding, but the last leg bought nothing new: price ran from the 2026-08-07 close of $152.05 to $161.64 on 2026-08-21 with no guidance change since the 2026-07-28 beat-and-raise — just a fifth covering… ICLR ICON plc MEDIUM Restatement discount still unwinding, now with a balance-sheet leg: on 2026-08-06 ICON priced $2.15B of unsecured notes to repay the bridge facility, all secured term loans and the 5.809% 2027 notes, releasing collateral. The 2026-08-21… IDYA IDEAYA Biosciences, Inc. MEDIUM Approval leg intact but between catalysts: the OptimUM-02 win (HR 0.42, ASCO 2026-06-01) feeds a rolling NDA under FDA RTOR guided complete H2 2026, and Q2 (2026-08-04) showed ~$1.24B cash with runway into 2030. Nothing company-dated until… IESC IES Holdings, Inc. MEDIUM Q3 FY26 (2026-07-31) resolved the post-index-inclusion fade in the bulls' favour — revenue $1.243B (+40%), backlog $4.53B (+91% since FY25 close), Communications +51% — and the 2-for-1 split distributing 2026-08-21 is the only dated event… IKT Inhibikase Therapeutics, Inc. MEDIUM Tape has caught up to the story: after FDA Orphan Drug Designation (2026-07-23) and a Q2 print (2026-08-11) showing 43 sites live across 26 countries and $159.0M cash, IKT closed $2.41 on 2026-08-14, 2.4% off its 52-week high. What is… ILMN Illumina, Inc. MEDIUM Post-print give-back fully reversed: $187.96 on 2026-08-07 to a 52-week-high close of $219.40 on 2026-08-21 (+51.9% over three months, RSI 66.3) with no new operating news since the 2026-07-30 beat-and-raise. Price now sits above the… IMAX Imax Corp MEDIUM Premium-large-format royalty narrative is maturing rather than breaking: price closed $52.74 on 2026-08-21, 1.8% off the $53.71 high, with RSI(14) cooling 74.5→55.5 since 2026-08-07 as Rosenblatt raised to $60 on 2026-08-10. No company… IMOS ChipMOS TECHNOLOGIES INC. MEDIUM Memory-cycle re-rating in an AI costume just re-accelerated: June 2026 revenue +37.2% YoY and Q2 +28.7% YoY (both records since 2014, reported 2026-07-10) erase the May deceleration scare, and price bought back the ~17% fade to sit ~$68… INNV InnovAge Holding Corp. MEDIUM Post-sanctions PACE turnaround got its first sell-side validation above market: KeyBanc to Overweight, $13 target, 2026-08-21. The 2026-08-21 close of $10.96 reclaims the $10.50 shelf lost on the 2026-08-11 close of $10.23. The 2026-09-08… JRSH Jerash Holdings (US), Inc. MEDIUM Sourcing-migration story now two-for-two on guidance: Q1 FY2027 revenue $50.23M (+26.7% YoY) beat consensus and the company's own guide on 2026-08-10, Q2 guided $49–51M vs $47.85M, DA Davidson to $6 on 2026-08-11. Since then the… KEYS Keysight Technologies, Inc. MEDIUM Analyst-migration re-rate's second leg (Morgan Stanley to Overweight, PT $400, 2026-07-13) has stalled — silent tape near 28x forward, empty calendar until the ~2026-08-19 Q3 FY26 print. The $290–300 breakout-shelf entry hasn't come;… KMTS Kestra Medical Technologies, Ltd. MEDIUM Wearable-defibrillator share-capture story accelerating: FY26 revenue $95.1M (+59%), fiscal Q4 $28.6M (+66%) with gross margin 54.8% vs 44.3%, plus JPMorgan's 2026-08-10 Overweight/$30 initiation. Price closed $26.99 on 2026-08-21, 4.8%… KMX CarMax Inc. MEDIUM Turnaround re-rating went live in July: KMX broke the $50–$53 shelf to close $57.33 on 2026-07-17 (+17.2% in five sessions) after a Q1 FY27 blowout (EPS $1.31 vs ~$0.95, revenue $8.01B +6.2%), CEO Keith Barr buying 9,400 shares at $53.005… KNSA Kiniksa Pharmaceuticals International, plc MEDIUM Post-print commercial re-rating still working but no longer fed by new information: the 2026-07-28 FY26 ARCALYST guidance raise to $980–995M and the 07-29/07-30 target ladder are three weeks old, the 08-12 Canaccord fireside produced no… KODK Eastman Kodak Company MEDIUM AM&C inflection is now the entire story: the 2026-08-04 Q2 print put segment revenue at $105M (+40% YoY) and consolidated operational EBITDA at $36M vs $9M, and the ~$9.20 shelf reclaimed on that print has held — the 2026-08-21 close was… KRO Kronos Worldwide, Inc. MEDIUM TiO2 earnings inflection printed 2026-08-05 (Q2 EPS $0.13 vs -$0.04 consensus, segment profit $41.0M vs $10.9M) is now two weeks old and consolidating rather than extending: 2026-08-21 close $8.20, 5.2% under the $8.65 52-week high, RSI… LAD Lithia Motors, Inc. MEDIUM Legacy dealer group re-rating on non-store earnings: the 2026-07-29 Q2 beat ($10.03 adj EPS vs $8.78) was carried by Driveway Finance while same-store revenue fell 1.6%. Since then only re-marking — Barclays $360 to $415 on 2026-08-19 —… LBRX LB Pharmaceuticals Inc fresh MEDIUM Single-asset schizophrenia binary where the sell-side frame flipped above the tape: BMO $54 (2026-08-12), Stifel $53 (08-13), Clear Street $69 (08-20) against a 2026-08-21 close of $47.62 and an $51.5 eight-analyst average. The 2026-08-11… LFST LifeStance Health Group, Inc. MEDIUM Margin-inflection pivot is delivered and now being repriced by the sell-side rather than by the company: BTIG went to $18 on 2026-08-19, price closed 2026-08-21 at $12.47 (2.8% under the $12.83 high, RSI 71.9, +68.7% in three months), and… LIND Lindblad Expeditions Holdings Inc. MEDIUM Post-catalyst drift, not a broken story: the 2026-08-03 beat (revenue $199.2M vs $185.85M est, occupancy 91%) carried price to a $34.48 high, and with nothing scheduled before the ~2026-11-03 Q3 print it has bled to $31.09 with RSI 36.1.… LPG Dorian Lpg Ltd MEDIUM Hormuz truce collapsed 2026-07-08 — Iran re-struck shipping and re-closed the Strait, re-firing VLGC rates to fresh 2026 highs (BLPG3 $220/ton, TCE $125k/day, week of Jul 10). This pure-play VLGC name re-accelerated off its $36 late-June… LRMR Larimar Therapeutics, Inc. MEDIUM Single-asset FA binary, now basing rather than breaking: the 2026-08-04 Q2 update held anaphylaxis at 10 of 43, reported no new urticaria after antihistamine premedication, and put cash at $156.3M with runway into Q3 2027. Rolling BLA… MASS 908 Devices Inc. fresh MEDIUM Post-divestiture handheld chemical-detection pure play re-rating on the 2026-08-11 beat-and-raise (revenue $16.07M vs $15.37M est, FY floor lifted to $68–70M) plus Roth $13 / Stifel $12 target hikes on 08-12. The 2026-08-21 close of $10.68… MAX MediaAlpha, Inc. MEDIUM Q2 (2026-07-29) beat and the Q3 guide cleared consensus, yet price has drifted from $13.79 on the print to $12.94 on 2026-08-21, 9.3% under the $14.27 high. Two post-print target raises (RBC $15 on 08-05, Canaccord $17 on 08-12) against no… MBX MBX Biosciences, Inc. MEDIUM Single-asset execution story: oPTimize Phase 3 in canvuparatide is guided to start by 2026-09-30 and sites are already screening. Since 2026-08-15 the sell-side re-rated on no new data — consensus $88.36 across 12 analysts (2026-08-23) vs… MCS The Marcus Corporation MEDIUM Theatrical-recovery narrative has cooled from overbought without breaking: RSI(14) 40.8 at the 2026-08-21 close of $29.57 versus 87.0 two weeks earlier, while domestic box office YTD widened to $6.868B, +20.2% YoY (Box Office Mojo,… MEI Methode Electronics MEDIUM Data-center power pivot is revenue-confirmed — record >$80M FY26 segment sales and an FY27 guide ($1.025–1.075B vs ~$952M Street) — but the post-print momentum leg has faded ~26% from the $20.38 high to ~$15. The re-rate is spent and the… MGNI Magnite, Inc. MEDIUM Q2 (2026-08-05) resolved the binary upward — CTV contribution ex-TAC $97.1M, +36% YoY, above the $90–92M guide; FY26 growth raised to 13–14% and eight target raises followed on 2026-08-06/07. The CTV/commerce-media compounding leg is… MGTX MeiraGTx Holdings plc MEDIUM The $400M Oberland royalty deal (2026-07-07) took dilution and runway risk off the table and spiked MGTX to a new 52-week high of $15.35 before a fade to ~$12.44 — a non-dilutive re-rate of a three-program AAV gene-therapy pipeline, but… MIRM Mirum Pharmaceuticals, Inc. MEDIUM Rare-disease franchise ran to a $125 ATH on FOP data, then cooled ~9% into a confirmed 2026-07-30 Q2 print. Base compounds (Q1 sales +43% YoY, FY guide $660–680M) with FOP PDUFA 2026-09-26 and HDV Phase 3 topline 2H26 stacked ahead — but… MLKN MillerKnoll, Inc. MEDIUM July's stall under $23.18 resolved upward: new 52-week high $24.49, $23.83 close on 2026-08-14, with no new company data since the 2026-06-24 Q4 report. The leg is multiple expansion (~11.9x the $2.00 FY2027 midpoint) into Rule 144 notices… MMED MiniMed Group, Inc. MEDIUM Carve-out re-rate extended: MMED closed $20.45 on 2026-08-21, through the prior $20.48 high, after Flex began U.S. shipment integrated with Abbott's Instinct sensor on 2026-08-17 — the last open product item. Reimbursement and integration… MRNA Moderna, Inc. MEDIUM First-ever positive Phase 3 for an mRNA cancer therapy (INTerpath-001, 2026-08-19) re-rated MRNA 177.0% in one session to $174.38 and swapped the flu-vaccine binary for an oncology-platform story. The narrative is accelerating; the entry… MYRG MYR Group, Inc. MEDIUM AI/datacenter power-buildout supercycle lifting grid/electrical contractors; MYRG confirmed it with a record Q1 and a late-June breakout to fresh ATHs (~$487) above the $484.71 shelf. Theme accelerating + cluster-confirmed, but the Q2… NAVN Navan, Inc. MEDIUM The wait-for-base setup flagged in July resolved upward: NAVN reclaimed the $25 IPO price and cleared the $28.22 post-IPO high, closing $29.25 on 2026-08-14 with RSI(14) at 78.5. Margin inflection on +34% Q1 growth is now confirmed by TD… NEOG Neogen Corporation MEDIUM Post-3M-integration cleanup is in the numbers after the 2026-07-30 beat-and-raise, but the re-rating has stopped extending: $11.95 close on 2026-08-21, a marginal new high at $12.15, RSI 50.8, no target change since Piper Sandler's $13 on… NESR National Energy Services Reunited Corp MEDIUM MENA national-oil-company capex via the only US-listed pure play; the 2026-08-05 $300M Kuwait award and the 2026-08-10 Q2 beat ($520.8M vs $446.97M) are fully in the tape. Headline flow stopped after the 2026-08-11 target raises and price… NET Cloudflare, Inc. MEDIUM Q2 (2026-08-06) put a number on the agent-traffic toll thesis: revenue $696.1M +36% YoY vs a $664–665M guide, net retention 120% (+6pts), FY26 guide up to $2.864–2.870B — and six target raises to $346–400 followed. Narrative now maturing:… NGNE Neurogene Inc. MEDIUM Rett gene-therapy story is now fully financed — pro forma cash ~$360.2M after the July raise, runway into Q1 2029 — and the 2026-08-11 Q2 print added safety breadth (N=35 at 1E15 vg as of 08-10) but zero new efficacy. Next hard binary is… NIQ NIQ Global Intelligence plc MEDIUM Beat-and-raise on 2026-08-10 flipped the frame: Q2 adjusted EBITDA margin 23.3% (vs 21.0% in Q1), FY26 adjusted EPS guided up to $1.08–1.12, net leverage 3.1x from 3.4x. The post-LBO deleveraging re-rate is now running, but +119.6% over… NKTR Nektar Therapeutics MEDIUM M&A read-through re-accelerating: AbbVie's $10.9B Apogee buyout (June 22, 2026) reframed NKTR as the next takeout-able Treg-IL-2 atopic-dermatitis asset, driving a ~25% run off the June low to ~$70. It's sympathy optionality, not fresh… NRIX Nurix Therapeutics, Inc. MEDIUM Roche-partnered BTK degrader moved from validation to execution: first patient in the registrational Phase 3 DAYBreak CLL-306 on 2026-08-04, RBC to $36 on 2026-08-10, price to a new 52-week high on 2026-08-14. Narrative still accelerating,… NSP Insperity, Inc MEDIUM Q2 binary resolved constructively on 2026-07-29: adj EPS $0.34 beat $0.32, and the FY worksite-employee guide floor was raised to 305,000 from 303,000 — the first guide that did not cut volume. Margin-repair re-rating carried price to a… NTSK Netskope, Inc. MEDIUM Sell-side caught up to the post-lockup repair leg — six coverage actions between 2026-08-14 and 2026-08-21 lifted the average target from $16.11 to $17.25 — while the tape stalled at $14.51 (2026-08-21) versus $14.87 on 2026-08-07. The… NVCR NovoCure Limited MEDIUM Post-TRIDENT commercial-inflection leg intact but undated: the 2026-07-23 Q2 print (rev $183.584M vs $172.437M cons., first positive adj. EBITDA $10.8M, FY guide to $710–725M) still sets the frame, and on 2026-08-22 Zacks flagged upward… NXT Nextpower Inc. MEDIUM Falling knife has based and turned: after a -34% unwind from the $163 high to a ~$107 June base, a fresh cluster (Truist initiate Buy $140 07-14, Guggenheim upgrade Buy 07-15) plus a 07-15 surge is re-rating the M&A-drift story. The… OII Oceaneering International Inc. MEDIUM Offshore earnings inflection (Q2 adj EBITDA $115M, FY guide $400–440M) is now fully re-rated: Citi's 2026-08-11 raise to $52 puts the anchor target at the tape, closing the sell-side gap that drove the July leg. Price $52.20 on 2026-08-14… OMDA Omada Health, Inc. MEDIUM Post-print re-rating has stalled into a two-week range — $23.89 on 2026-08-21 versus the $26.78 52-week high — after Q2 (2026-08-06) beat at $87.8M revenue (+43%) and lifted the FY guide to $334–340M. The 2026-09-10 first-ever Investor Day… ONC BeOne Medicines Ltd. MEDIUM Q2 print resolved bullish — revenue $1.705B vs $1.591B est., non-GAAP EPS/ADS $3.84 vs $1.44, FY26 guide raised to $6.6–6.8B — but the stock is still 7.9% under the $377.47 52-week high and the 2026-08-06 target wave was increments, not… OPRT Oportun Financial Corporation MEDIUM Margin-repair turnaround stalled at the highs rather than broken: after the 2026-08-05 Q2 beat ($0.42 adj EPS vs $0.33, adj EBITDA $49M vs a $34-39M guide) and an FY EBITDA raise to $160-175M, the stock peaked at $8.09 on 2026-08-07 and… ORKA Oruka Therapeutics, Inc. MEDIUM Supply overhang cleared: the 2026-07-01 Fairmount $300M block at $84.43 was absorbed and price closed $92.70 on 07-17 (+11.6%), 5% off the 52-week high, with 19.85% short interest still rising. Long-acting I&I re-rated by the $10.9B… OWL Blue Owl Capital Inc. MEDIUM Private-credit-stress bottom trade now digesting: price -1.7% from the 2026-08-07 close while RSI(14) unwound 83.9 to 58.1, and term funding reopened with $750M of 6.750% 2036 notes priced 2026-08-12. Nothing resolves the redemption… OXM Oxford Industries, Inc. MEDIUM Setup inverted since the June breakdown. OXM reclaimed its 200-day ($39.11) and 50-day ($39.94) off the $35.83 low, the CEO bought 2,500 shares at $36.90 on 2026-06-12, and ~$25M of filed IEEPA tariff-refund claims — 4% of market cap,… PBF PBF ENERGY INC. MEDIUM Post-Q2 refining super-margin narrative has matured into a sell-side target chase — Goldman $71 → $81 on 2026-08-18 — while the >10% holder sold five tranches between 2026-08-11 and 2026-08-17, the last at $74.79 into the $75.20 high. With… PCOR Procore Technologies, Inc. fresh MEDIUM Post-2026-07-29 re-rating (Q2 double beat, first GAAP operating profit, FY27 25% margin target, $845M DroneDeploy deal) has extended to $63.49 on 2026-08-21 with no new information behind it — no press release since 2026-08-06, no rating… PCTY Paylocity Holding Corporation MEDIUM Post-print re-rating leg: the 2026-08-04 Q4 FY26 beat ($1.84 adj. EPS vs $1.61 est.) triggered five price-target raises in 48 hours and a $150.42 close on 2026-08-07, +35.5% over three months. The buy is multiple recovery in mid-cap HCM… PD PagerDuty, Inc. MEDIUM The read has flipped from value trap to ownership story. Price reclaimed the 200-DMA (~$10.30 on 2026-07-17, +13% in three weeks), Truist lifted its PT to $11 on 2026-07-09, and the 2026-07-14 addition of Alex Shootman — who sold Workfront… PENG Penguin Solutions, Inc. MEDIUM Q3 (July 7) broke the model wide open: revenue $478.7M vs $405.5M consensus (+48% YoY), EPS $0.84 vs $0.54, FY26 growth guide lifted 12%→22% and FY27 pre-guided ~30%. The stock then round-tripped from $89.86 to ~$60 on the $750M… PENN PENN Entertainment, Inc. MEDIUM Q2 (2026-08-06) kept the digital turnaround on schedule — interactive adj-EBITDA loss $9.5M (+$52.5M YoY), Q4-2026 profitability target and $1.963B retail EBITDAR midpoint intact — but the tape decoupled: prediction-market headlines took… PGEN Precigen, Inc. MEDIUM PAPZIMEOS launch-ramp durability is the binary — the first FDA-approved RRP therapy printed $21.6M net product revenue in Q1 2026, and the now-confirmed Aug 4 Q2 print (announced Jul 21) grades whether the ramp compounds sequentially or… PK Park Hotels & Resorts Inc. MEDIUM The 2026-08-06 binary resolved upward — Q2 AFFO $0.70 vs $0.59 consensus, FY26 guide lifted to AFFO $1.90–$2.00 and RevPAR +3.0%–4.5%, July RevPAR tracking +8.5% PLMR Palomar Holdings, Inc. MEDIUM Beat-and-raise did not hold: Q2 (2026-08-04) printed GWP $630.5M +27% YoY, adjusted EPS $2.36 and a third FY26 guidance raise to $270–280M, yet the 2026-08-14 close is $128.21 against a $145.29 52-week high with RSI(14) 29.8. Earnings keep… PLPC Preformed Line Products Company MEDIUM The July rollover read was voided by the 2026-07-29 Q2 print: sales $212.7M vs $193M consensus, EPS $4.49 vs $2.41, and a ~30% one-session repricing to a new all-time closing high of $480.77 (2026-08-11). Grid/AI-power second-order… PNRG PrimeEnergy Resources Corporation MEDIUM Geopolitical crude bid re-fired after the 2026-07-08 US strikes and Hormuz blockade — WTI back to ~$80 from $68.86, PNRG +8.9% MTD to $186.51 and above the 200-day. Structurally better than June: GCX in-service flipped Waha gas positive,… PPTA Perpetua Resources Corp. MEDIUM Funded domestic-antimony story re-accelerating on the 2026-07-30 US Army/INL pilot plant and the 2026-08-06 gold-tungsten discovery (21.3 m @ 3.2 g/t Au, 0.9% W). But the 2026-08-14 close of $25.24 sits 32.2% under the $37.22 52wk high… PRCH Porch Group, Inc. fresh MEDIUM Reciprocal-pivot re-rate has largely printed: $9.26 (6/5) to $15.98, now consolidating at $13.68 after KBW's 7/13 valuation downgrade that still raised its target to $16.25. Narrative intact but maturing; the 2026-08-04 Q2 print is the… PRGS Progress Software Corporation MEDIUM Disciplined software roll-up ("Total Growth Strategy") re-rated by a fresh catalyst cluster: Q2 beat + FY guide raise (2026-06-30) and the $400M Domo buy (2026-07-22). Special-situations theme active, but a maturing low-beta compounder —… PRM Perimeter Solutions, Inc. MEDIUM Monopoly wildfire retardant (PHOS-CHEK) into a season at national Preparedness Level 5 — 3.85M acres burned YTD (NIFC, 7/18), ~157% of the 10-yr average. JPM initiated Overweight $50 on 7/9, lifting the 4-analyst average target to $45.… PTGX Protagonist Therapeutics, Inc. MEDIUM De-risked dual-royalty story accelerating into a binary: icotrokinra (oral IL-23, J&J) already approved and paying 6–10% royalties; rusfertide (PV, Takeda) into a Q3 2026 PDUFA. Stock at a fresh ATH ($143.29, Jul 20) as the PV theme runs —… PUBM PubMatic, Inc. MEDIUM Ad-tech SSP growth inflection re-rated as an AI story: Q2 2026 revenue $78.593M (+11% YoY) beat a $68.875M consensus and the Q3 guide of $75–77M cleared $71.092M consensus. Two weeks on, the 2026-08-07 gap has held — the 2026-08-21 close… PVLA Palvella Therapeutics, Inc. MEDIUM First-approved-therapy-for-microcystic-LM story still working: the 2026-08-04 Q2 update reaffirmed rolling-NDA completion in H2 2026 and potential approval H1 2027, and the stock closed $156.13 on 2026-08-14, 1.0% under its 52-week high.… QNST QuinStreet, Inc. MEDIUM The Aug 6 binary resolved up: Q4 revenue $373.9M (+43% YoY) beat $359.9M consensus, FY2027 guided to $1.45–1.55B revenue / $150–160M adj EBITDA, and the stock gapped +35.9% on Aug 7 to a fresh 52-week high of $22.02. Carrier ad-spend… QTWO Q2 Holdings Inc MEDIUM Post-print re-rate has stalled into consolidation: the 2026-07-29 beat-and-raise (FY26 $881–886M, 28.6% adj. EBITDA margin, +$350M buyback) still stands, but no analyst action since 2026-07-31, RSI decay from 70.4 to 55.6, and two officer… RAPP Rapport Therapeutics, Inc. MEDIUM RAPP broke to all-time highs at $42.62 (2026-07-17, +6.2%) on zero company news — the move is pure sell-side re-rating (BTIG reiterated Buy/$65 on 7/16, consensus PT $56.64, 12 desks Strong Buy) with Phase 3 FOCUS now enrolling globally.… RCKT Rocket Pharmaceuticals, Inc. MEDIUM First clean RP-A501 datapoint in 15 months — three Danon patients dosed at the recalibrated 3.8×10¹³ GC/kg with no TMA or capillary leak (2026-08-03) — turned a bleeding chart into a mid-range one. The re-rate still needs the undated H2… REAL The RealReal, Inc. MEDIUM The 2026-08-06 binary resolved bullish — record GMV $617M (+22%), adj EBITDA $13.5M at a 7.0% margin, FY GMV guide lifted to $2.535–2.565B — and the tape did not re-rate: $11.40 on 2026-08-14 versus ~$11.37 on 2026-07-23, still 32.5% under… RELY Remitly Global, Inc. MEDIUM Operating-leverage leg still working: Q2 on 2026-08-05 delivered Adjusted EBITDA +79% on revenue +20% and a raised FY guide of $1.978–1.988B / $410–415M. Since then the only new information has been supply — directors sold 2026-08-12… RLAY Relay Therapeutics, Inc. MEDIUM Coverage-driven leg intact but thinning: HC Wainwright's $29 raise (2026-08-20) was the fourth in 14 days and the first that failed to make a new high, with the 2026-08-21 close at $19.44 versus a $20.75 52-week high. No dated company… RMAX Re/Max Holdings, Inc. fresh MEDIUM Merger arb that finally got a date. DOJ granted HSR early termination 2026-07-13 and both special meetings are set for 2026-08-14, removing the regulatory leg. RMAX $11.10 vs ~$11.86 blended (5.150 REAX at $2.21 plus the prorated $13.80… RPD Rapid7, Inc. MEDIUM Q2 (2026-08-10) flipped RPD from a pure take-private probe to a cost-out re-rating: ARR still -2.0% YoY at $824M, but EPS beat $0.44 vs $0.35, a 12% headcount cut targets 20% Q4 operating margin, and FY26 EPS guide went to $1.78-1.83.… RRGB Red Robin Gourmet Burgers, Inc. fresh MEDIUM Deleveraging turnaround repricing: ~$96M / 116-unit refranchising cuts net debt ~$147M→~$51M, removing the going-concern tail that pinned RRGB near $2.46. Tape +38.7% since the ~2026-05-20 Q1 print, into the low-$7s near the $7.89 high.… SCZM Santacruz Silver Mining Ltd. MEDIUM Silver-zinc producer re-rating: Nasdaq debut 2026-01-21, Glencore's US$40M base price cleared October 2025, Q1 2026 revenue $127.5M (+81% YoY), Q2 silver output +17% QoQ. RSI(14) 80.5 on the 2026-08-14 close of $8.85 after a flat quarter —… SE Sea Limited MEDIUM Three-engine re-acceleration — Shopee GMV +30%, Monee loan book +71%, Garena's best quarter in 5 years — drove a Q1 beat (2026-05-12) and a +19% one-month recovery off the $77 low. Fundamentally accelerating, but the stock is short-term… SEPN Septerna, Inc. MEDIUM Re-accelerated on the 2026-08-10 Q2 beat (revenue $26.746M vs $17.875M est; EPS $(0.29) vs $(0.43)) plus SEP-479 Phase 1 PK color: new all-time high $48.19, close $44.50 on 2026-08-14, and five broker target raises in four sessions… SHIP Seanergy Maritime Holdings Corp. MEDIUM Capesize spot printed $40,170/day on 2026-08-20, roughly 30% above the ~$30,998/day the company guided for Q3 on 2026-07-30 — yet the stock closed $17.50 on 2026-08-21, still 3.7% under its $18.17 high. No company print until… SIBN SI-BONE, Inc. MEDIUM The 2026-08-03 binary resolved bullish: Q2 revenue $56.01M (+15.2% YoY vs +11.2% in Q1), EPS −$0.09 vs −$0.15 est, FY26 floor raised to $231M, three target hikes on 2026-08-04. Price cleared the $17.05 shelf that capped June–July.… SKWD Skyward Specialty Insurance Group, Inc. MEDIUM Q2 beat on 2026-08-04 (op EPS $1.30 vs $1.17 est, combined 89.5%, 19% operating ROE) cleared the binary, but four target raises through 2026-08-11 met a lower price — $59.80 on 2026-08-14, 8.9% under the $65.63 high, RSI 45.3. maturing:… SMRT SmartRent, Inc. MEDIUM RSI(14) cooled 87.8→74.7 while price only slipped $1.49→$1.43, so the momentum extreme unwound sideways. Still no dated catalyst until the ~November Q3 print. SNAP Snap Inc. fresh MEDIUM Q2 (2026-08-03) inverted the broken-pivot frame: revenue +19% YoY to $1.6B, adj EBITDA $250M (+$208M YoY), Other Revenue +85%; ten desks lifted targets 2026-08-04 and the uniform $5 wall became $5.25–$8. The buy is a… SNDK Sandisk Corporation MEDIUM Cycle stock re-rating into a contracted-revenue story: Q4 (2026-08-05) revenue $8.965B, +372% YoY, GM 84.6%, and the 2026-08-13 Investor Day's ~$94B of guaranteed-volume customer agreements re-accelerated a theme that read saturated in… SNDR Schneider National, Inc. MEDIUM The 2026-07-30 print resolved the binary in the bulls' favour — adj EPS $0.29 vs $0.23 consensus, FY26 guide raised to $0.90–$1.10 from $0.70–$1.00 — yet the 2026-08-14 close of $36.10 sits 6.6% under the 2026-06-08 high, with SONAR… SNDX Syndax Pharmaceuticals, Inc. MEDIUM Menin-inhibitor commercial ramp accelerating: Revuforj + Niktimvo franchise cleared $100M/quarter with revenue +224% YoY, and the leg being bought is frontline AML label expansion (~10x TAM). Stock coils below 52-week-high resistance… SPSC SPS Commerce, Inc. MEDIUM De-rating-repair leg: Q2 (2026-07-30) beat on adjusted EPS $1.27 vs $1.09 with EBITDA +19% on 6% revenue growth, while the FY26 revenue band was cut on the 2026-06-30 3P divestiture. Price reclaimed the ~$70 200-day, but the fresh Morgan… SPXC SPX Technologies, Inc. MEDIUM Q2 beat-and-raise on 2026-07-30 was the strongest print of the cycle — HVAC backlog $919M (+59% organic), 2026 data-center revenue set at $430M, capacity target lifted to $1.1B from $750M — yet the 2026-08-14 close of $217.32 sits 11.8%… TBLA Taboola.com Ltd. MEDIUM Legacy open-web ad network repricing as a toll booth on AI answer surfaces: the 2026-06-16 DeeperDive ad-network launch (35% take rate, open to third-party LLMs/agents) plus the 2026-07-01 Wikitree win drove a breakout to 52-week highs… TEAM Atlassian Corporation MEDIUM The "agentic AI kills seat-based software" de-rating just reversed: Q4 FY26 (2026-08-06) put cloud +31% and $6,606M subscription ARR behind the Rovo/MCP agent story, and the stock gapped 30%+ on 2026-08-07 to close $149.07. The… TNET Trinet Group, Inc. MEDIUM The 2026-07-30 binary resolved bullish: Q2 ICR 86% vs 90%, adj EPS $1.55 vs $0.93 est, FY adj-EPS guide raised to $4.50-5.10. Shares made a 52wk high at $71.67 and sit 4.1% under it. The leg now being bought is durability, not recovery —… TOI The Oncology Institute, Inc. MEDIUM Q2 (2026-08-06) delivered the first positive adjusted EBITDA (+$0.2M) and a FY26 guide raise to $650–670M revenue with the EBITDA floor lifted to $2M, but the July refi spike already round-tripped and RSI was 32 into the print. Shares also… TRVI Trevi Therapeutics, Inc. MEDIUM Second breakout leg confirmed: TRVI cleared the June $18.17 all-time high and printed $20.22 on a +9.85% July 17 session (8.3M shares, $19.07 close), lifting the tape ~+45% in six weeks on Phase 3 launch mechanics and institutional… TTMI TTM Technologies, Inc. MEDIUM The 2026-08-05 binary resolved bullishly — Q2 revenue $1.004B beat both the $930–970M guide and $962M consensus, book-to-bill rose to 1.49, Q3 guided $1.100–1.140B vs $1.073B consensus. Yet the 2026-08-14 close of $140.0 is 36.8% below the… TVTX Travere Therapeutics, Inc. MEDIUM Q2 beat on 2026-08-04 ($169.6M revenue vs $159.6M consensus; FILSPARI US sales +96% YoY to $141.1M) re-opened sell-side headroom — six target raises 08-05→08-10 into a $70–85 band while the 2026-08-14 close of $62.14 sits 1.0% under the… TWLO Twilio Inc. MEDIUM Legacy CPaaS repricing as voice/agentic-AI engagement infrastructure; sell-side re-clustered higher into the print — Cowen $245, Mizuho $240, Citizens $250 (2026-07-17/20) — but the 2026-07-30 Q2 report is now the binary deciding whether… TWST Twist Bioscience Corporation MEDIUM Synthetic-DNA-as-AI-input narrative went vertical: the failed $70 breakout reclaimed and ran to a $105.47 high, +200%+ YTD with 85% of it since the 2026-05-21 analyst day. Targets now $102-$120 but price sits above the $85.50 consensus and… U Unity Software Inc. MEDIUM Legacy pivot has now printed: Q2 (2026-08-06) Grow revenue $329.0M +63% YoY, Vector past $1B ARR two quarters early, GAAP breakeven pulled into Q3 2026, four Hold-to-Buy upgrades on 2026-08-07. But the 2026-08-14 close of $46.25 sits… UFPT UFP Technologies, Inc. MEDIUM MedTech outsourcing compounder re-rated on the 2026-08-03 Q2 beat — organic growth 12.4% vs 6.8% for the first half, adj EPS $2.92 vs $2.50 consensus — carrying price to within 3.9% of the $334.84 52-week high. Narrative accelerating,… UGP Ultrapar Participacoes S.A. MEDIUM Q2 (6-K 2026-08-12, call 2026-08-13) delivered the margin re-rate — Ipiranga EBITDA R$2.782B at R$451/m³, record cash flow, leverage 0.9x, lowest since 2008 — then management guided Q3 margins below that level. Price faded to 6.1% under… UHAL U-Haul Holding Company MEDIUM Storage-plus-capital-return re-rating held through a weak print: Q1 FY2027 (2026-08-05) missed on EPS ($0.58 vs $0.69 est.) yet the stock made a new 52-week high at $75.27, helped by disposal losses reversing $24.0M to a $1.9M gain. Now… ULCC Frontier Group Holdings, Inc. MEDIUM Fuel-relief leg replaced by an earnings-delivery leg: the 2026-07-29 Q2 print put adjusted EPS at $(0.10) against a $(0.60)–$(0.45) May guide on record $1,279M revenue, and guided 2H to breakeven-or-better. The catch is that guide assumes… URGN UroGen Pharma Ltd. MEDIUM The 2026-08-05 binary resolved upward: ZUSDURI Q2 net revenue $50.4M (+73% QoQ off the $29.2M Q1 base), total revenue $72.456M vs $63.526M consensus, and a ~22% one-day gap to a $49.00 52-week high. The ramp now runs into an empty calendar… UROY Uranium Royalty Corp. MEDIUM Corporate re-rating from the 2026-07-27 Sweetwater close is now fully priced-in news; RSI(14) 79.9 on 2026-08-21 with no company headline since 2026-08-07, and no combined-company financials exist before the ~2026-09-14 first quarterly… VAC Marriott Vacations Worldwide Corporation MEDIUM Q2 (2026-08-06) resolved the turnaround binary upward: contract sales $545M +22%, adj EPS $2.31 vs $1.97 est, FY adj EBITDA guide lifted to $805–830M from $755–780M. Price cleared the July $105.97 high to a $120.99 close (2026-08-14) and… VCYT Veracyte, Inc. MEDIUM Sell-side is now chasing a move it missed: VCYT broke to a 52-wk high $60.91 (closed $59.13 on 2026-07-17, +124% YoY) as Piper initiated Overweight $66 (07-15) and Canaccord lifted a Hold PT $42→$60. Fundamentals still accelerating (Q1 rev… VET Vermilion Energy Inc. MEDIUM European gas did the work: TTF above €65/MWh on 2026-08-20 (+~130% YTD) with EU storage at a record-low 57.1% for the date on 2026-08-01, and the shares moved from the 2026-08-07 close of $10.86 to $12.73, now 11.1% under the $14.32 high.… VG Venture Global, Inc. MEDIUM LNG-export narrative re-accelerating on Europe's winter gas scramble plus a Middle East risk premium; VG ran +23% off the $12 mid-July shelf to $14.31 as Plaquemines ramps and CP2 advances. The 2026-08-11 pre-market Q2 print is the binary… VLO Valero Energy Corporation MEDIUM Refiner crack spreads at a record ~$70/bbl 3-2-1 as a Hormuz/Iran supply shock idles ~10% of global refining; VLO is the pure-play margin leverage and the fundamental leg is accelerating. But sell-side (6 PT raises in 11 days) and CNBC… VOYG Voyager Technologies, Inc. MEDIUM Defense-space order flow re-rating: Q2 (2026-08-03) delivered record $113.0M bookings, 2.1x book-to-bill, $335.5M backlog and an FY26 guide raise to $275–305M, followed by Raytheon SM-3 and Space Force awards. Starlab/NASA optionality sits… VSTM Verastem, Inc. MEDIUM Post-Q2 the narrative is confirmed and the tape has flattened: $6.74 on 2026-08-07 to $6.89 on 2026-08-21 while three banks cut targets with ratings held. The 2026-08-28 Oberland closing funds $50M inside 30 days; the October VS-7375… WEX WEX Inc. MEDIUM Hated fuel-card/fintech inflecting: the 2026-07-22 Q2 beat (Adj EPS $5.35 vs $5.05) and FY26 guide raise to $19.68-$20.08 discredit the EV-kills-fuel-cards and rate-cut-kills-float bear case; PTs jumped to $200-210 (Mizuho/KBW, 7/24).… WIX Wix.com Ltd. fresh MEDIUM Base44 margin inversion is the live leg and the market is now paying up for it: after the 2026-08-04 beat ($563.1M, +15%; adj EPS $1.39 vs $1.16) and the ~60% 2H gross-margin guide, price ran from the 2026-08-07 close of $60.20 to $66.14… WNC Wabash National Corp. MEDIUM The tariff re-rating now has a fundamental leg under it: Q2 (2026-07-29) beat on revenue at $417.2M and backlog rose 14% q/q to $956M, the first Q2 order-book build. The binary is regulatory — Commerce's final China AD/CVD determination is… WTTR Select Water Solutions, Inc. MEDIUM Q2 (2026-08-04) underwrote the produced-water re-rate — record $101.6M Water Infrastructure revenue, $92.7M Adjusted EBITDA, EPS $0.17 vs $0.13 — and shares made a new 52-week high $22.18 before easing to $20.86. Consensus PT ~$22.29 is… XNCR Xencor, Inc. MEDIUM Two overhangs closed in three weeks: the $105M Alexion settlement (2026-07-29) ended the Ultomiris dispute and pushed runway through 2028, and Q2 revenue of $51.2M vs $18.9M consensus (2026-08-05) drew three price-target raises on 08-06.… YETI YETI Holdings, Inc. MEDIUM Tariff-margin-recovery turnaround now getting sell-side confirmation: Goldman upgraded to Buy/$63 on 2026-07-20 (vs Canaccord's $45 Hold a month earlier), pushing YETI through the $51.89 multi-year high. The leg still hinges on the… ZBIO Zenas BioPharma, Inc. MEDIUM First-in-disease B-cell modulator: obexelimab BLA (IgG4-RD, 56% flare cut, HR 0.44) hit the FDA 2026-05-28, and the ~60-day filing determination — acceptance plus a possible Priority Review grant — is due within days, a fresh near-term… ZETA Zeta Global Holdings Corp. fresh MEDIUM Palantir Foundry re-platforming now has a management clock — phase one guided complete within 30–40 days of the 2026-07-06 Citi event, landing on the ~2026-08-04 Q2 print. Price reclaimed the $21 shelf that capped the June recovery (+14%… ZURA Zura Bio Limited MEDIUM Q2 print (2026-08-11) added a third tibulizumab indication — polymyalgia rheumatica, NEXUS-PMR Phase 2 by YE2026 — and Wedbush ($22) plus Guggenheim ($20) raised targets on 2026-08-12; the $5.57 close on 2026-08-14 has not paid for it. The…